NFKB1 and diffuse large B-cell lymphoma: Somatic mutations in TRAF3, CARD11, CD79A/B, TNFAIP3/A20 and MYD88, which activate the NF-κB signaling pathway, were identified in EBV- DLBCL [12–15].